- Home
- MYRG vs MLTX Comparison
MYRG vs MLTX Comparison
Compare MYRG & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYRG
- MLTX
- Stock Information
- Founded
- MYRG 1891
- MLTX 2021
- Country
- MYRG United States
- MLTX Switzerland
- Employees
- MYRG N/A
- MLTX N/A
- Industry
- MYRG Water Sewer Pipeline Comm & Power Line Construction
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- MYRG Industrials
- MLTX Health Care
- Exchange
- MYRG Nasdaq
- MLTX Nasdaq
- Market Cap
- MYRG 2.5B
- MLTX 2.8B
- IPO Year
- MYRG N/A
- MLTX N/A
- Fundamental
- Price
- MYRG $183.60
- MLTX $49.00
- Analyst Decision
- MYRG Buy
- MLTX Strong Buy
- Analyst Count
- MYRG 5
- MLTX 7
- Target Price
- MYRG $171.60
- MLTX $73.33
- AVG Volume (30 Days)
- MYRG 168.5K
- MLTX 463.2K
- Earning Date
- MYRG 07-30-2025
- MLTX 08-06-2025
- Dividend Yield
- MYRG N/A
- MLTX N/A
- EPS Growth
- MYRG N/A
- MLTX N/A
- EPS
- MYRG 2.12
- MLTX N/A
- Revenue
- MYRG $3,380,348,000.00
- MLTX N/A
- Revenue This Year
- MYRG $6.56
- MLTX $103.42
- Revenue Next Year
- MYRG $6.14
- MLTX N/A
- P/E Ratio
- MYRG $86.83
- MLTX N/A
- Revenue Growth
- MYRG N/A
- MLTX N/A
- 52 Week Low
- MYRG $86.60
- MLTX $31.42
- 52 Week High
- MYRG $190.81
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- MYRG 65.15
- MLTX 63.01
- Support Level
- MYRG $181.10
- MLTX $46.37
- Resistance Level
- MYRG $185.45
- MLTX $49.29
- Average True Range (ATR)
- MYRG 5.52
- MLTX 1.85
- MACD
- MYRG -0.44
- MLTX 0.05
- Stochastic Oscillator
- MYRG 69.36
- MLTX 88.30
About MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.